Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2014, Article ID 608521, 5 pages
Case Report

Metastatic Squamous Cell Carcinoma of the Anus to the Lung Confirmed with Allelotyping

1Department of Pathology, The Ohio State University Wexner Medical Center, 410 West 10th Avenue, Columbus, OH 43210, USA
2Division of Thoracic Surgery, The Ohio State University Wexner Medical Center, 410 West 10th Avenue, Columbus, OH 43210, USA
3Head and Neck Pathology and Cytopathology, Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA
4Department of Oncologic Sciences and Department of Pathology and Cell Biology, University of South Florida, Tampa, FL 33620, USA

Received 9 November 2013; Accepted 2 January 2014; Published 9 February 2014

Academic Editors: A. Agrawal, Z. Schaff, and T. Yuri

Copyright © 2014 Rachel Roth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Histopathologic techniques are insufficient for distinguishing primary squamous cell carcinoma (SCC) from metastatic SCC, which is clinically important. A patient with SCC of the anus was found to also have SCC of the lung, and the question of metastatic versus synchronous primary diseases was raised. Immunohistochemical and hematoxylin and eosin (H&E) staining on sections of tissue could not discriminate between the two entities. Immunostain for p16 and chromogenic in situ hybridization for human papillomavirus (HPV) type 16 were positive in both tumors. Additionally, allelotyping for loss of heterozygosity displayed similar findings and confirmed the histopathological impression of anal SCC metastasis to the lung. The patient was treated with palliative chemotherapy instead of additional surgical treatment. When multiple tumors are present, determining metastatic versus synchronous primary tumors is necessary for appropriate treatment. Identification can be achieved using allelotyping for loss of heterozygosity.